Skip to main content
OpenTrials
Completed

NCT Number: NCT05508412

Cancer Patient Empowerment Program: Phase 2 Feasibility Study

The Cancer Patient Empowerment Program is a comprehensive health promotion program aiming to improve the quality of life as well as both physical and mental health in cancer patients and survivors. The program includes daily email communications over 6 months that encourage strength and aerobic exercise, yoga, stress reduction techniques, dietary improvements, and more.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

QEII Health Sciences Centre

Halifax, Nova Scotia, B3H 2Y9, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >18.
  • History of a cancer diagnosis as per the participant's report.
  • Safe to exercise and do strength training. Participants who have recovered from a minor stroke or heart condition in the past will require approval from their Family Physician or Cardiologist to participate in the study.
  • Participants with advanced cancer (including cancer spread to bones) will need approval from the Study Physician or their Oncologist to participate.
  • Existing (or willingness to create) email account and willingness to access email daily.
  • Ability to follow website links to watch YouTube videos.
  • Ability to understand and speak English.
  • Ability to participate in low to moderate levels of physical activity and strength training.
  • Ability and willingness to fill out an online survey at baseline, and 6, 12 and possibly 24 months, and a weekly compliance survey for the six months of the program.
  • Deemed to have an expected survival greater than 1 year and expected to be well enough to complete the six-month training

Exclusion criteria

  • Patients deemed unfit to participate in low to moderate level exercise e.g., including but not limited to a myocardial infarction or stroke within the last year, without approval from their Family Physician or Cardiologist that they are safe to exercise.
  • Unable to access the internet and lack of a computer or smartphone to receive emails required for study intervention, or unable to click on a link to successfully watch a YouTube video.
  • Those with a predicted survival less than 1 year, or not expected to be able to participate in the program for six months.

Treatment and study plan

CancerPEP

Behavioral

CancerPEP

Primary outcomes

  1. Feasibility (accrual, attrition, compliance, and adverse events)

    Time frame: 6 - 24 months

    As measured by accrual, attrition, compliance rates, and safety by number of adverse events.

Secondary outcomes

  1. Mental Health as assessed by the Kessler Kessler Psychological Distress Scale (K10)

    Time frame: 6 - 24 months

    A 10 item questionnaire that assesses psychological distress. The scale has a score range of 10-50, with higher scores indicating worse mental health.

  2. General Health (Physical and Mental) Quality of Life assessed by the 12-item Short Form Health Survey (SF-12)

    Time frame: 6 - 24 months

    A 12 item questionnaire. The scale has a score range of 0-100, with higher scores indicating better physical and mental health functioning.

  3. Health-Related Quality of Life as assessed by the Functional Assessment of Cancer Therapy - General (FACT-G)

    Time frame: 6 - 24 months

    A 27 item questionnaire that measures the four domains of HRQOL in cancer patients: Physical, social, emotional, and functional well-being. The scale has a score range of 0-108, with higher scores indicating better quality of life.

  4. Personality as assessed by the Ten-Item Personality Inventory (TIPI)

    Time frame: 6 - 24 months

    A 10 item questionnaire assessing the Big-Five personality dimensions (Extraversion, Agreeableness, Conscientiousness, Emotional Stability, Openness to Experiences). The scale has a score range of 1-14 for each dimension with higher scores indicating a higher level of that personality trait.

  5. Alcohol Habit assessed by questions from the NIH Alcohol Consumption questionnaire.

    Time frame: 6 - 24 months

    Questions assessing alcohol consumption

  6. Smoking habit assessed by the Global Adult Tobacco Survey 2020 (GATS).

    Time frame: 6 - 24 months

    Questions assessing smoking use

  7. Diet assessed by the Rapid Eating Assessment for Participants (REAP-S).

    Time frame: 6 - 24 months

    A 16 item questionnaire assessing diet quality. The scale has a score range of 13-39 with a higher score indicating a higher diet quality.

  8. Comorbidity level assessed by the modified Charlson Comorbidity Index (CCI)

    Time frame: 6 - 24 months

    Each category is scored from 1-6. The higher the score, the more likely the predicted outcome will result in mortality or higher resource use.

  9. Availability of social support assessed by the MOS Social Support Survey

    Time frame: 6 - 24 months

    A 19 item questionnaire that assesses emotional/informational support, positive social interaction, tangible support and affectionate support. Higher item scores reflect a higher level of social support.

  10. Sleep Quality as assessed by the Pittsburgh Sleep Quality Index (PSQI)

    Time frame: 6 - 24 months

    A 19 item questionnaire that assesses sleep quality and disturbances. The scale has a score range of 0-21 with a higher score indicating worse sleep quality.

  11. Sedentary behaviour measured by the Sedentary Behaviour Questionnaire (SBQ) for Adults.

    Time frame: 6 - 24 months

    Two 9 item questionnaires (weekday and weekend) with each item scored to none to 6 hours or more. The total score is the sum of the amount of time and as it increases it indicates higher amount of sedentary behaviour.

  12. Sexual functioning in women assessed by the 6-item Female Sexual Function Index (FSFI-6).

    Time frame: 6 - 24 months

    A 6-item shortened version of the original index. Items are rated on a 5-point Likert scale, ranging from 1 to 5, and the other items are rated on a 6-point Likert scale, ranging from 0 to 5. Total scores range from 2 to 30, with lower scores indicating worse sexual functioning.

  13. Sexual functioning in men assessed by the Sexual Health Inventory in Men (SHIM).

    Time frame: 6 - 24 months

    A 5-item questionnaire with scores ranging from 1-25 and lower scores indicating worse sexual functioning.

  14. Anxiety severity assessed by the GAD-7.

    Time frame: 6 - 24 months

    A 7 item questionnaire with scores ranging from 0-21 higher scores indicating more severe level of anxiety.

  15. Relationship satisfaction as assessed by the Dyadic Adjustment Scale (DAS-32).

    Time frame: 6 - 24 months

    A 32 item questionnaire that measure an individual's perceptions of their relationship with an intimate partner. The scale has a total score range of 1-151 with a higher score indicating better satisfaction.

  16. Center for Epidemiologic Studies Depression Scale (CES-D).

    Time frame: 6 - 24 months

    A 20 item questionnaire with a possible range of scores from zero to 60, with the higher scores indicating the presence of more depressive symptomatology.

  17. Satisfaction with Life Scale (SWLS).

    Time frame: 6 - 24 months

    A 5 item questionnaire that was designed to measure subjective well-being. Scores range from 5-35 with higher scores indicating higher satisfaction with life.

  18. Brief Illness Perception Questionnaire (IPQ).

    Time frame: 6 - 24 months

    A 9 item sale that measures an individual's beliefs, feelings, and cognitive representations of one's illness.

Sponsors and collaborators

Lead sponsor

Nova Scotia Health Authority

Other

Collaborators

  • Dalhousie University

Registry information

Official study title

CancerPEP Phase 2 Randomized Trial: Feasibility of a Comprehensive Cancer Patient Empowerment Program Providing Immediate Versus Delayed Stress Reduction Biofeedback Equipment

Acronym: CancerPEP

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Aug 19, 2022
Registry last updated
Mar 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.